Athira Pharma Inc (ATHA)

Finanzdaten der Athira Pharma Inc-Aktie (ATHA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Research and Development	10.32% 21.24	23.68	27.20	21.61	21.29
Costs And Expenses	4.57% 27.69	29.01	35.04	31.64	29.77
Operating Income/Loss	4.57% -27.69	-29.01	-35.04	-31.64	-29.77
Income/Loss From Continuing Operations Before Tax	3.47% -26.34	-27.29	-35.04	-29.60	-27.82
Income/Loss From Continuing Operations After Tax	3.47% -26.34	-27.29	-32.97	-29.60	-27.82
Net Income/Loss	3.47% -26.34	-27.29	-32.97	-29.60	-27.82
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	140.89K% 38.32	0.0272	38.05	38.00	37.92
Diluted Average Shares	140.89K% 38.32	0.0272	38.05	38.00	37.92
Basic Earnings Per Share	2.82% -0.69	-0.71	-0.87	-0.78	-0.73
Diluted Earnings Per Share	2.82% -0.69	-0.71	-0.87	-0.78	-0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-